|
[1] Chen W, Zhou X B, Liu H Y, et al. P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice. Br J Pharmacol, 2009,157(5):724-735.
[2] Wang H, Xiao J, Gao D, et al. Pharmacophore-based design, synthesis, and biological evaluation of novel chloro-pyridazine piperazines as human rhinovirus (HRV-3) inhibitors. Bioorg Med Chem Lett, 2011, 21(3):1057-1059.
[3] Fan S Y, Zheng Z B, M i CL, et al. Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors. Bioorg Med Chem, 2009,17(2):621-624.
[4] Zhao L J, Wang Y Y, Li G, et al. Functional features of RUNX1 mutants in acute transformation of chronic myeloid leukemia and their contribution to inducing murine full-blown leukemia. Blood, 2012, doi: 10.1182/blood - 2011-08-370981.
[5] Li X H, Zou H J, Wu A H, et al. Structure-based drug design of a novel family of chalcones as PPARalpha agonists: virtual screening, synthesis, and biological activities in vitro. Acta Pharmacol Sin, 2007, 28(12):2040-2052.
[6] 何新华, 谢云德, 肖鹤等. 新型CD4抑制剂J2的合成及其活性评价. 中国药物化学杂志, 2009,19 (4): 290-292. He X H, Xie Y D, Xiao H, et al. Synthesis of J2 as a novel CD4 antagonist. Chinese Journal of Medicinal Chemistry, 2009,19 (4): 290-292.
[7] 张春叶, 王东凯, 徐松林, 等. 盐酸川丁特罗片的制备和质量控制. 中国新药杂志. 2007,16(1):1788-1790. Zhang C Y, Wang D K, Xu S L, et al. Preparation and quality control of trantinterol hydrochloride tablets. Chinese Journal of New Drugs, 2007,16(1):1788-1790.
[8] 崔一民, 赵侠, 孙培红,等. 单次口服盐酸川丁特罗片在健康人体的耐受性和药代动力学. 中国临床药理学杂志. 2008, 24(1): 25-28. Cui Y M, Zhao X, Sun P H, et al. Tolerability and pharmacokinetics of tratinterol hydrochloride tablets in healthy subjects after a single dose administration. The Chinese Journal of Clinical Pharmacology, 2008, 24(1): 25-28.
|
